Literature DB >> 17698665

Cis-acting elements in the antigenomic promoter of Nipah virus.

Pramila Walpita1, Clarence J Peters.   

Abstract

Genome synthesis in paramyxoviruses, including Nipah virus (NiV), is controlled by sequence elements that reside in the non-coding nucleotides at the 5'-trailer (3'-antigenomic) end that make up the antigenomic promoter (AGP). Using a chloramphenicol acetyl transferase-based plasmid-driven minigenome system, the terminal 96 nt of NiV AGP were first mutagenized in blocks of three hexamers to enable broad mapping of the minigenome functional regions. This was followed by further dissection of these functional regions to define the cis-acting elements contained therein. Results based on RNA analysis and reporter gene activity identified a bipartite promoter structure similar to that seen in related viruses, but with some distinct differences: in NiV, each of the two discrete replication control elements was bimodal, characterized by a critical conserved region (nt 1-12 and 79-91) and a contiguous non-conserved region (nt 13-36 and 73-78), which appeared less important. The regulatory role of these less critical regions was underscored by the use of a two-step mutation strategy, which revealed the additive detrimental effect of substitutions in this part of the terminal element. The structure and sequence characteristics of the internal control element was also different: it involved four contiguous hexamers, and the region encompassing three of these (nt 79-96, corresponding to hexamers 14, 15 and 16), although analogous in position to the equivalent element in the Sendai virus AGP, was characterized by the distinct 5'-(GNNNUG)(14-15)(GNNNNN)(16) motif.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698665     DOI: 10.1099/vir.0.83035-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Analysis of nucleotides 13-96 of the human parainfluenza virus type 3 antigenomic promoter reveals positive- and negative-acting replication elements.

Authors:  Jill R Gander; LeeAnne M Schwan; Michael A Hoffman
Journal:  Virology       Date:  2011-08-30       Impact factor: 3.616

Review 2.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

Review 3.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 4.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

5.  The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Authors:  Sven Enterlein; Kristina M Schmidt; Michael Schümann; Dominik Conrad; Verena Krähling; Judith Olejnik; Elke Mühlberger
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

6.  Vaccine potential of Nipah virus-like particles.

Authors:  Pramila Walpita; Jennifer Barr; Michael Sherman; Christopher F Basler; Linfa Wang
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

7.  Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase.

Authors:  Paul C Jordan; Cheng Liu; Pauline Raynaud; Michael K Lo; Christina F Spiropoulou; Julian A Symons; Leo Beigelman; Jerome Deval
Journal:  PLoS Pathog       Date:  2018-02-09       Impact factor: 6.823

8.  Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.

Authors:  Michael K Lo; Mark E Peeples; William J Bellini; Stuart T Nichol; Paul A Rota; Christina F Spiropoulou
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.